[9] There were 522 residents of the municipality who were employed in some capacity, of which females made up 40.6% of the workforce
In 2025, a pill version of Wegovy was also approved for weight loss
The STEP 1 trial data was striking: participants lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% on placebo. Then came March 2022
Though human studies with CLA are still in their infancy, CLA has been shown to reduce fat mass (albeit somewhat modestly) in humans
Ozempic/semaglutide is recommended for patients with specific clinical indications, budget considerations, or thin-fat phenotype without high insulin resistance
A GLP-1 Core plan designed to support weight management, appetite control, and metabolic balance with weekly injections